Legal Representation
Attorney
John V. Hobgood, Esquire
USPTO Deadlines
Application History
46 events| Date | Code | Type | Description |
|---|---|---|---|
| Dec 20, 2021 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Dec 20, 2021 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| May 22, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| May 21, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| May 21, 2021 | EX5G | S | SOU EXTENSION 5 GRANTED |
| May 13, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 13, 2021 | EXT5 | S | SOU EXTENSION 5 FILED |
| Feb 2, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Feb 2, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Feb 2, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Feb 2, 2021 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Feb 2, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Feb 2, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Nov 17, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Nov 13, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Nov 13, 2020 | EXT4 | S | SOU EXTENSION 4 FILED |
| Nov 13, 2020 | EX4G | S | SOU EXTENSION 4 GRANTED |
| May 15, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| May 13, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 13, 2020 | EXT3 | S | SOU EXTENSION 3 FILED |
| May 13, 2020 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Nov 15, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Nov 13, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Nov 13, 2019 | EXT2 | S | SOU EXTENSION 2 FILED |
| Nov 13, 2019 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Jul 24, 2019 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Jul 24, 2019 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| May 14, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| May 11, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 11, 2019 | EXT1 | S | SOU EXTENSION 1 FILED |
| May 11, 2019 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Nov 13, 2018 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Sep 18, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Sep 18, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Aug 29, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Aug 10, 2018 | ALIE | A | ASSIGNED TO LIE |
| Aug 1, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Aug 1, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Aug 1, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Aug 1, 2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Feb 28, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Feb 28, 2018 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Feb 28, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Feb 21, 2018 | DOCK | D | ASSIGNED TO EXAMINER |
| Jan 10, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Dec 26, 2017 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 016
Printed medical publications, namely, reports, manuals, brochures, newsletters, leaflets relating to the diagnosis and/or treatment of genetic diseases and diseases relating to gene sequence or gene expression and/or information regarding genetic medicines
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Scientific and medical research relating to the diagnosis and/or treatment of genetic diseases and related diseases; product development and consultancy in the field of biotechnology, biologics, pharmaceutics, medical science, chemistry and biochemistry
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Providing a web site featuring information relating to the diagnosis and/or treatment of genetic diseases and related diseases; therapeutic gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of genetic diseases and related diseases
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the words "GENERATION BIO" in stylized letters.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
016
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"BIO"